📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Comparison of SARS-CoV-2 Evolution in Paediatric Primary Airway Epithelial Cell Cultures Compared with Vero-Derived Cell Lines (2022)

First Author: Bamford C

Attributed to: Repurposing FDA-Approved Drugs for Treatment of 2019-nCoV-induced Disease funded by COVID

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.3390/v14020325

PubMed Identifier: 35215919

Publication URI: http://europepmc.org/abstract/MED/35215919

Type: Journal Article/Review

Parent Publication: Viruses

Issue: 2

ISSN: 1999-4915